Development asset linked to Shenzhen Second People's in public FDA and regional records.
pharma · Leukemia, Lymphocytic, Acute, B-Cell · Prostate Cancer Indications
Shenzhen Second People's
Shenzhen Second People's Hospital
Shenzhen Second People's drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 4
- Patents
- 0
Shenzhen Second People's pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Shenzhen Second People's drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Shenzhen Second People's in public FDA and regional records.
-
Development asset linked to Shenzhen Second People's in public FDA and regional records.
-
Development asset linked to Shenzhen Second People's in public FDA and regional records.